Current findings have confirmed the importance of cDC1s in the DNLs in mediating an effective antigen-specific CD8+T cells anti-tumor response, and in establishing a favorable response to ICIs therapy in HNSCC (81, 82). This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.